Vir Biotechnology Inc

Research Vir Biotechnology Inc (VIR) on Bullrun: market cap USD 1.75B. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerVIR
• ExchangeNASDAQ
• CountryUnited States
• SectorHealthcare
• IndustryBiotechnology
• CurrencyUSD
• Market capUSD 1.75B
• Financial periodFY2025
• RevenueUSD 68.56M
• Revenue growth-7.6%
• Net income-USD 437.99M
• Free cash flow-USD 396.61M
• Gross margin100.0%

Valuation Snapshot

latest market cap is USD 1.75B.

About Vir Biotechnology Inc

Vir Biotechnology, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapeutic products to treat and prevent serious infectious diseases in the United States and internationally. Its clinical development pipeline consists of product investigational therapies targeting hepatitis delta virus (HDV) and other solid tumors. The company's preclinical candidates include those targeting influenza A and B antibodies and antibody drug conjugates, and coronavirus monoclonal antibodies;

Frequently asked questions

What is Vir Biotechnology Inc's market cap?

Vir Biotechnology Inc's market capitalization is USD 1.75B.

What does Vir Biotechnology Inc do?

Vir Biotechnology, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapeutic products to treat and prevent serious infectious diseases in the United States and internationally.